[68Ga]Ga-XT771
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [68Ga]Ga-XT771, covering 2025-07-16 to 2025-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma [EARLY_Phase 1]